Outcome | Total n = 5010 | Pen-A patients n = 1254 | Non-Pen-A patients n = 3756 | Unadjusted OR | 95% CI | Adjusted OR | 95% CI |
---|---|---|---|---|---|---|---|
No. of patients treated with | |||||||
≥1 AB prescription per patient yearc,e | 497 (9.9%) | 238 (19.0%) | 259 (6.9%) | 3.16 | 2.617–3.822 | 2.56 a | 2.046–3.197 |
≥1 2nd choice AB prescriptions per patient yeard,e | 47 (0.9%) | 18 (1.4%) | 29 (0.8%) | 1.26 | 1.008–1.582 | 2.21 a | 1.107–4.402 |
≥1 Tetracyclinse | 68 (1.4%) | 35 (2.8%) | 33 (0.9%) | 3.24 | 2.004–5.235 | 2.24 | 1.287–3.887 |
≥1 Beta-lactam, penicillinse | 101 (2.0%) | 30 (2.4%) | 71 (1.9%) | 1.27 | 0.826–1.959 | 0.80 | 0.482–1.342 |
≥1 Beta-lactam, otherse | 2 (0.0%) | 1 (0.1%) | 1 (0.0%) | 3.00 | 0.187–47.947 | 6.09 | 0.360–103.149 |
≥1 Sulfonamides and trimethoprime | 32 (0.6%) | 18 (1.4%) | 14 (0.4%) | 3.89 | 1.930–7.849 | 2.07 | 0.908–4.724 |
≥1 Macrolides, lincosamides and streptograminse | 64 (1.3%) | 53 (4.2%) | 11 (0.3%) | 15.02 | 7.823–28.855 | 8.69 | 4.261–17.728 |
≥1 Quinolonese | 34 (0.7%) | 15 (1.2%) | 19 (0.5%) | 2.38 | 1.206–4.700 | 2.59 | 1.221–5.479 |
≥1 Other antibacterialse | 82 (1.6%) | 30 (2.4%) | 52 (1.4%) | 1.75 | 1.109–2.749 | 1.31 | 0.767–2.231 |
No. of patients with | |||||||
≥4 GP contacts per patient yearc,e | 2353 (47.0%) | 761 (60.7%) | 1592 (42.4%) | 2.10 | 1.845–2.396 | 1.71 b | 1.460–1.999 |